155 related articles for article (PubMed ID: 27743382)
1. MMP inhibitor Ilomastat induced amoeboid-like motility via activation of the Rho signaling pathway in glioblastoma cells.
Yan S; Xue H; Zhang P; Han X; Guo X; Yuan G; Deng L; Li G
Tumour Biol; 2016 Oct; ():. PubMed ID: 27743382
[TBL] [Abstract][Full Text] [Related]
2. Vincristine enhances amoeboid-like motility via GEF-H1/RhoA/ROCK/Myosin light chain signaling in MKN45 cells.
Eitaki M; Yamamori T; Meike S; Yasui H; Inanami O
BMC Cancer; 2012 Oct; 12():469. PubMed ID: 23057787
[TBL] [Abstract][Full Text] [Related]
3. X-ray irradiation and Rho-kinase inhibitor additively induce invasiveness of the cells of the pancreatic cancer line, MIAPaCa-2, which exhibits mesenchymal and amoeboid motility.
Fujita M; Otsuka Y; Yamada S; Iwakawa M; Imai T
Cancer Sci; 2011 Apr; 102(4):792-8. PubMed ID: 21214671
[TBL] [Abstract][Full Text] [Related]
4. SOX2-RNAi attenuates S-phase entry and induces RhoA-dependent switch to protease-independent amoeboid migration in human glioma cells.
Oppel F; Müller N; Schackert G; Hendruschk S; Martin D; Geiger KD; Temme A
Mol Cancer; 2011 Nov; 10():137. PubMed ID: 22070920
[TBL] [Abstract][Full Text] [Related]
5. Metastasis of aggressive amoeboid sarcoma cells is dependent on Rho/ROCK/MLC signaling.
Kosla J; Paňková D; Plachý J; Tolde O; Bicanová K; Dvořák M; Rösel D; Brábek J
Cell Commun Signal; 2013 Jul; 11():51. PubMed ID: 23899007
[TBL] [Abstract][Full Text] [Related]
6. Modulation of phorbol ester-induced regulation of matrix metalloproteinases and tissue inhibitors of metalloproteinases by SB203580, a specific inhibitor of p38 mitogen-activated protein kinase.
Park MJ; Park IC; Hur JH; Kim MS; Lee HC; Woo SH; Lee KH; Rhee CH; Hong SI; Lee SH
J Neurosurg; 2002 Jul; 97(1):112-8. PubMed ID: 12134900
[TBL] [Abstract][Full Text] [Related]
7. RhoA/ROCK signaling mediates plasticity of scirrhous gastric carcinoma motility.
Matsuoka T; Yashiro M; Kato Y; Shinto O; Kashiwagi S; Hirakawa K
Clin Exp Metastasis; 2011 Oct; 28(7):627-36. PubMed ID: 21667311
[TBL] [Abstract][Full Text] [Related]
8. Rho-kinase inhibitor, fasudil, suppresses glioblastoma cell line progression in vitro and in vivo.
Deng L; Li G; Li R; Liu Q; He Q; Zhang J
Cancer Biol Ther; 2010 Jun; 9(11):875-84. PubMed ID: 20364104
[TBL] [Abstract][Full Text] [Related]
9. Reduced expression of the ROCK inhibitor Rnd3 is associated with increased invasiveness and metastatic potential in mesenchymal tumor cells.
Belgiovine C; Frapolli R; Bonezzi K; Chiodi I; Favero F; Mello-Grand M; Dei Tos AP; Giulotto E; Taraboletti G; D'Incalci M; Mondello C
PLoS One; 2010 Nov; 5(11):e14154. PubMed ID: 21209796
[TBL] [Abstract][Full Text] [Related]
10. Three-dimensional hydrogel is suitable for targeted investigation of amoeboid migration of glioma cells.
Huang Y; Tong L; Yi L; Zhang C; Hai L; Li T; Yu S; Wang W; Tao Z; Ma H; Liu P; Xie Y; Yang X
Mol Med Rep; 2018 Jan; 17(1):250-256. PubMed ID: 29115617
[TBL] [Abstract][Full Text] [Related]
11. Diverse matrix metalloproteinase functions regulate cancer amoeboid migration.
Orgaz JL; Pandya P; Dalmeida R; Karagiannis P; Sanchez-Laorden B; Viros A; Albrengues J; Nestle FO; Ridley AJ; Gaggioli C; Marais R; Karagiannis SN; Sanz-Moreno V
Nat Commun; 2014 Jun; 5():4255. PubMed ID: 24963846
[TBL] [Abstract][Full Text] [Related]
12. Hyaluronic acid induces ROCK-dependent amoeboid migration in glioblastoma cells.
Cui Y; Cole S; Pepper J; Otero JJ; Winter JO
Biomater Sci; 2020 Sep; 8(17):4821-4831. PubMed ID: 32749402
[TBL] [Abstract][Full Text] [Related]
13. Dual Targeting of Mesenchymal and Amoeboid Motility Hinders Metastatic Behavior.
Jones BC; Kelley LC; Loskutov YV; Marinak KM; Kozyreva VK; Smolkin MB; Pugacheva EN
Mol Cancer Res; 2017 Jun; 15(6):670-682. PubMed ID: 28235899
[TBL] [Abstract][Full Text] [Related]
14. Resveratrol suppresses human glioblastoma cell migration and invasion via activation of RhoA/ROCK signaling pathway.
Xiong W; Yin A; Mao X; Zhang W; Huang H; Zhang X
Oncol Lett; 2016 Jan; 11(1):484-490. PubMed ID: 26870238
[TBL] [Abstract][Full Text] [Related]
15. Rho/ROCK pathway inhibition by the CDK inhibitor p27(kip1) participates in the onset of macrophage 3D-mesenchymal migration.
Gui P; Labrousse A; Van Goethem E; Besson A; Maridonneau-Parini I; Le Cabec V
J Cell Sci; 2014 Sep; 127(Pt 18):4009-23. PubMed ID: 25015295
[TBL] [Abstract][Full Text] [Related]
16. ROCK signaling mediates the adoption of different modes of migration and invasion in human mammary epithelial tumor cells.
Torka R; Thuma F; Herzog V; Kirfel G
Exp Cell Res; 2006 Nov; 312(19):3857-71. PubMed ID: 17010335
[TBL] [Abstract][Full Text] [Related]
17. Zoledronic Acid Inhibits the RhoA-mediated Amoeboid Motility of Prostate Cancer Cells.
Pietrovito L; Comito G; Parri M; Giannoni E; Chiarugi P; Taddei ML
Curr Cancer Drug Targets; 2019; 19(10):807-816. PubMed ID: 30648509
[TBL] [Abstract][Full Text] [Related]
18. PEITC inhibits human brain glioblastoma GBM 8401 cell migration and invasion through the inhibition of uPA, Rho A, and Ras with inhibition of MMP-2, -7 and -9 gene expression.
Chou YC; Chang MY; Wang MJ; Yu FS; Liu HC; Harnod T; Hung CH; Lee HT; Chung JG
Oncol Rep; 2015 Nov; 34(5):2489-96. PubMed ID: 26352173
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of MMPs supports amoeboid angiogenesis hampering VEGF-targeted therapies via MLC and ERK 1/2 signaling.
Chillà A; Anceschi C; Frediani E; Scavone F; Del Rosso T; Pelagio G; Tufaro A; De Palma G; Del Rosso M; Fibbi G; Chiarugi P; Laurenzana A; Margheri F
J Transl Med; 2023 Feb; 21(1):102. PubMed ID: 36759828
[TBL] [Abstract][Full Text] [Related]
20. Reduced WNT5A signaling in melanoma cells favors an amoeboid mode of invasion.
Jobe NP; Åsberg L; Andersson T
Mol Oncol; 2021 Jul; 15(7):1835-1848. PubMed ID: 33969605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
